Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04688710 · ClinicalTrials.gov registry record · NA
Use of Audio Recordings of Self-Hypnosis and Meditation for Fatigue Management in Multiple Sclerosis
A NA study, sponsored by University of Washington.
- Completed
- Registry status
- NA
- Development phase
- 333
- Enrollment target
NCT04688710 is a NA study that has completed, run by University of Washington. The registered enrollment target is 333 participants.
The verdict
NCT04688710, a NA study, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- NA
- Development phase
- 333 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the effectiveness of two self-guided psychological treatments, Self-Hypnosis (HYP) and Mindfulness Meditation (MM) compared to Treatment as Usual (TAU) for people with multiple sclerosis (MS) and clinically significant fatigue.
Interventions
- BEHAVIORAL Mindfulness Meditation (MM)
- BEHAVIORAL Self-Hypnosis (HYP)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 333 participants |
| Start Date | 2021-04-30 |
| Est. Completion | 2023-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04688710
The ClinicalTrials.gov registry entry for NCT04688710 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 333 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Mindfulness Meditation (MM) is the first listed.
NCT04688710 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04688710 about?
NCT04688710 is a clinical study titled "Use of Audio Recordings of Self-Hypnosis and Meditation for Fatigue Management in Multiple Sclerosis". The purpose of this study is to assess the effectiveness of two self-guided psychological treatments, Self-Hypnosis (HYP) and Mindfulness Meditation (MM) compared to Treatment as Usual (TAU) for people with multiple sclerosis (MS) and clinically significant fatigue.
What is the current status of trial NCT04688710?
This trial is currently completed. It is a NA study. The enrollment target is 333 participants. The study started on 2021-04-30. Estimated completion is 2023-12-31.
What interventions are being tested in trial NCT04688710?
The interventions under investigation include: Mindfulness Meditation (MM) (BEHAVIORAL), Self-Hypnosis (HYP) (BEHAVIORAL).
Who is sponsoring clinical trial NCT04688710?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.